Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human KCNK6 ELISA Kit (AC2516)
Cat.#: ASET-1105
Specifications
Description Human KCNK6 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human KCNK6 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.021 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2038 Human ABCG1 ELISA Kit (AC3449) Quantitative inquiry ASET-2287 Human HMT ELISA Kit (AC3698) Quantitative inquiry ASET-1090 Human GLP-1R ELISA Kit (AC2501) Quantitative inquiry ASET-1658 ACTH ELISA Kit (AC3069) Quantitative inquiry ASET-1251 Human PICALM ELISA Kit (AC2662) Quantitative inquiry ASET-2288 Rat CX3CR1 ELISA Kit (AC3699) Quantitative inquiry ASET-1065 Mouse Visfatin ELISA Kit (AC2476) Quantitative inquiry ASET-2467 Human Attractin ELISA Kit (AC3878) Quantitative inquiry ASET-2430 Human KCNK15 ELISA Kit (AC3841) Quantitative inquiry ASET-1867 Human Visfatin ELISA Kit (AC3278) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket